Clinical research on advanced liver cancer treated with percutaneous RFA cool-tip electrode under ultrasound guidance
- VernacularTitle:超声引导下经皮射频消融治疗中晚期肝癌的临床研究
- Author:
Shixi CHENG
;
Guowen YING
;
Weidong XU
;
Wei XI
;
Ming ZHANG
- Publication Type:Journal Article
- Keywords:
Cool-tip electrode;
Radiofrequency ablation;
Ultrasound-guided;
Advance liver caner;
Arterial embolization.
- From:
Journal of Interventional Radiology
1992;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical efficacy and complications in the treatment of advance liver cancer under ultrasound guidance with percutaneous RFTI-1 TM-cold cycle RF tumor ablation apparatus produced by Nangjing TianMa high-tech Company limited. Methods 25 patients of advance liver cancer, including 8 cases of metastatic liver cancer, 17 of primary hepatic carcinoma, were treated with percutaneous RFA cool-tip electrode under Ultrasound guidance 1 to 2 times. Eight of the patients prior to RFA were treated with TACE of individually three times for each. The postoperative efficacy was evaluated by enhanced CT. Results 10 lesions were completely necrotized and the majority parts of another 15 lesions were also under necrosis. Follow-up of six months, all patients are still alive with marked improvement of life quality. Conclusion The short-term efficacy of percutaneous Ultrasound-guided RFA with cool-tip electrode for treating advance liver cancer is quite satisfied, worthy to be recommended.
